Picture of Ergomed logo

ERGO Ergomed Cashflow Statement

0.000.00%
gb flag iconLast trade - 00:00
HealthcareSpeculativeMid CapHigh Flyer

Annual cashflow statement for Ergomed, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

C2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-10.84.9912.614.315
Depreciation
Non-Cash Items7.723.340.4762.732.81
Unusual Items
Other Non-Cash Items
Changes in Working Capital2.61-0.2520.101-3.36-8.78
Change in Accounts Receivable
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities2.111.81818.714.8
Capital Expenditures-1.59-0.996-0.974-0.983-1.92
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-2.2-1.83-11.8-3.16-24.2
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3.79-2.83-12.8-4.15-26.1
Financing Cash Flow Items-0.1870-0.157-0.169-0.761
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities3.77-0.25-0.477-2.11-2.37
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1.979.074.7412.2-12.1